Napabucasin drug page Clinical trials

Trials with Napabucasin

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

2Trials
0Recruiting
12Countries
1.308Planned patients

Showing 1–2 of 2

Special Combination of BBI608 and Pembrolizumab
Finished Phase 1 55 patients NCT02851004

the efficacy and safety of BBI608 in combination with pembrolizumab

Japan Oct 2016 – Aug 2021 Interventional
Combined with: Pembrolizumab
A Study of Napabucasin (BBI-608) in Combination With FOLFIRI in Adult Patients With Previously Treated Metastatic Colorectal Cancer
Finished Phase 3 1.253 patients NCT02753127

This is an international multi-center, prospective, open-label, randomized, adaptive design phase 3 trial of the cancer stem cell pathway inhibitor napabucasin plus standard bi-weekly FOLFIRI versus standard bi-weekly FOLFIRI in patients w…

United States, Australia, Belgium, Canada and 7 more Jun 2016 – May 2021 Interventional